Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia

Romiplostim is a thrombopoietin receptor agonist (TPO-RA) used for the treatment of adult primary immune thrombocytopenia (ITP). ITP is an autoimmune condition characterized by low platelet counts due to increased destruction and reduced platelet production. First-line interventions include corticos...

Descripción completa

Detalles Bibliográficos
Autor principal: Perdomo, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970631/
https://www.ncbi.nlm.nih.gov/pubmed/27529057
http://dx.doi.org/10.2147/ITT.S80648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970631/
https://www.ncbi.nlm.nih.gov/pubmed/27529057
http://dx.doi.org/10.2147/ITT.S80648

Ejemplares similares